You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 021009

✉ Email this page to a colleague

NDA 021009 describes ALOCRIL, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. Additional details are available on the ALOCRIL profile page.

The generic ingredient in ALOCRIL is nedocromil sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nedocromil sodium profile page.

Summary for 021009

Tradename:	ALOCRIL
Applicant:	Allergan
Ingredient:	nedocromil sodium
Patents:	0

Pharmacology for NDA: 021009

Physiological Effect	Decreased Histamine Release

Medical Subject Heading (MeSH) Categories for 021009

Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents

Suppliers and Packaging for NDA: 021009

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ALOCRIL	nedocromil sodium	SOLUTION/DROPS;OPHTHALMIC	021009	NDA	Allergan, Inc.	0023-8842	0023-8842-05	1 BOTTLE, DROPPER in 1 CARTON (0023-8842-05) / 5 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Dec 8, 1999	TE:		RLD:	Yes

Expired US Patents for NDA 021009

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	ALOCRIL	nedocromil sodium	SOLUTION/DROPS;OPHTHALMIC	021009-001	Dec 8, 1999	4,474,787	⤷ Get Started Free
Allergan	ALOCRIL	nedocromil sodium	SOLUTION/DROPS;OPHTHALMIC	021009-001	Dec 8, 1999	RE38628	⤷ Get Started Free
Allergan	ALOCRIL	nedocromil sodium	SOLUTION/DROPS;OPHTHALMIC	021009-001	Dec 8, 1999	4,760,072	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.